At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 101 enrolled
Drug / intervention
Provodine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Skin and Soft Tissue Infection (SSTI) Study
The University of Texas Health Science Center at San Antonio·interventional·Posted Nov 9, 2015·Updated Oct 30, 2018
In Brief
A Phase 4 clinical trial evaluating Provodine and Incision and Drainage for Skin Diseases, Infectious and Soft Tissue Infections. Completed, enrolled 101 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if the use Provodine as an antiseptic and hand wash once daily for at least 7 days will have better healing, better health outcomes, fewer treatment failures and fewer infections themselves and among their household contacts than those who do not use Provodine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Diseases, Infectious, Soft Tissue Infections
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 2015
Enrollment StartDec 2015
Primary CompletionApr 2017
Study CompletionMay 2017
TodayJul 2026
First PostedNov 9, 2015
Enrollment StartDec 1, 2015
Primary CompletionApr 30, 2017
Study CompletionMay 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.6 years ago
Interventions
Provodinedrug
Incision and Drainageprocedure